Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Eryn Callihan

Concepts (51)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pregnancy Complications, Neoplastic
1
2013
52
0.400
Why?
Carcinoma, Ductal, Breast
1
2013
82
0.400
Why?
Postpartum Period
2
2022
330
0.370
Why?
Breast Neoplasms
2
2022
2150
0.260
Why?
Neoplasm Invasiveness
1
2024
480
0.200
Why?
Cisplatin
1
2024
298
0.200
Why?
Neoadjuvant Therapy
1
2024
381
0.190
Why?
Urinary Bladder Neoplasms
1
2024
226
0.180
Why?
Carcinoma, Renal Cell
1
2023
180
0.180
Why?
Prostate-Specific Antigen
1
2021
162
0.180
Why?
Kidney Neoplasms
1
2023
350
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1573
0.120
Why?
Proportional Hazards Models
2
2022
1210
0.120
Why?
Prostatic Neoplasms
1
2021
1013
0.110
Why?
Myeloid Cells
1
2013
142
0.100
Why?
Lymphatic Metastasis
1
2013
318
0.100
Why?
Kaplan-Meier Estimate
1
2013
864
0.090
Why?
Risk
1
2013
856
0.090
Why?
Prognosis
2
2022
3788
0.080
Why?
Lymphocyte Activation
1
2013
1098
0.080
Why?
Multivariate Analysis
1
2013
1496
0.080
Why?
Melanoma
1
2013
752
0.060
Why?
Pregnancy
2
2022
6375
0.060
Why?
T-Lymphocytes
1
2013
1924
0.060
Why?
Vinblastine
1
2024
68
0.060
Why?
Cystectomy
1
2024
38
0.060
Why?
Deoxycytidine
1
2024
164
0.050
Why?
Chemotherapy, Adjuvant
1
2024
376
0.050
Why?
Methotrexate
1
2024
250
0.050
Why?
Doxorubicin
1
2024
322
0.050
Why?
Parity
1
2022
121
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2023
764
0.040
Why?
Biopsy
1
2021
1086
0.040
Why?
Humans
6
2024
129116
0.030
Why?
Aged, 80 and over
2
2021
7064
0.030
Why?
Retrospective Studies
1
2013
14571
0.030
Why?
Mass Screening
1
2021
1159
0.030
Why?
Blood Cell Count
1
2013
54
0.030
Why?
Adult
2
2013
35510
0.030
Why?
Female
3
2022
68510
0.030
Why?
Lipopolysaccharide Receptors
1
2013
88
0.030
Why?
Cohort Studies
1
2022
5407
0.020
Why?
T-Lymphocytes, Regulatory
1
2013
376
0.020
Why?
Survival Analysis
1
2013
1265
0.020
Why?
Neoplasm Staging
1
2013
1293
0.020
Why?
Flow Cytometry
1
2013
1142
0.020
Why?
Aged
2
2021
22083
0.020
Why?
Middle Aged
2
2022
31074
0.020
Why?
Disease Progression
1
2013
2613
0.020
Why?
Male
2
2021
63194
0.010
Why?
Young Adult
1
2013
12389
0.010
Why?
Callihan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)